The acquisition of Robocath represents a strategic expansion into advanced mechanical robotic technology for interventional cardiology and neurointerventions. However, the deal's success is contingent on Stereotaxis completing debt restructuring, which introduces execution risk. The earnout structure aligns incentives but also indicates uncertainty about Robocath's future performance. Monitor for updates on the debt restructuring and regulatory approvals.
Price Chart
Executive Summary
Stereotaxis is acquiring French robotics firm Robocath for $20 million upfront plus up to $25 million in earnouts, funded through a combination of cash, stock, and pre-funded warrants. This strategic acquisition expands Stereotaxis's interventional cardiology and neurointerventional robotics portfolio, though the deal is subject to debt restructuring and regulatory approvals.
Key Financial Metrics
Key Facts
- Stereotaxis is acquiring 100% of Robocath for $20 million upfront (cash, stock, or combination) plus up to $25 million in earnouts based on regulatory and commercial milestones
- The acquisition is subject to debt restructuring, French regulatory clearance, and other closing conditions
- Stereotaxis will provide interim financing of approximately €1.3 million to Robocath
- The stock consideration is capped at 19.9% of Stereotaxis's outstanding shares to avoid shareholder approval
- Robocath has agreed to restrictions on soliciting alternative acquisition proposals
Financial Impact
$20 million upfront plus up to $25 million in earnouts
Risk Factors
- The acquisition is subject to debt restructuring, which could fail
- Regulatory approval from French authorities is required
- The earnout payments are contingent on future performance, introducing uncertainty
- The stock consideration could lead to dilution of existing shareholders
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-016685 |
| Document: 0001493152-26-016685-index-headers.html | 0001493152-26-016685 |
| Document: 0001493152-26-016685-index.html | 0001493152-26-016685 |
| Document: 0001493152-26-016685.txt | 0001493152-26-016685 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 7w ago | Press Release | $1.39 $1.18 | ▼ −15.11% | ▼ −13.92% | $1.03 (−25.90%) |
Aug 14, 2026 10w ago | EFFECT | $1.38 $1.33 | ▲ +3.62% | ▲ +1.63% | $1.03 (+25.36%) |
Aug 14, 2026 10w ago | EFFECT | $1.38 $1.33 | ▲ +3.62% | ▲ +1.63% | $1.03 (+25.36%) |
Aug 11, 2026 10w ago | Press Release | $1.40 $1.30 | ▼ −7.14% | ▼ −5.25% | $1.03 (−26.43%) |
Jul 15, 2026 14w ago | S-3 | $1.65 $1.38 | ▲ +16.36% | ▲ +19.98% | $1.03 (+37.58%) |
Jul 15, 2026 14w ago | S-3 | $1.65 $1.38 | ▼ −16.36% | ▼ −19.98% | $1.03 (−37.58%) |
Jul 9, 2026 15w ago | 8-K | $1.74 $1.36 | ▼ −21.84% | ▼ −24.08% | $1.03 (−40.80%) |
May 12, 2026 23w ago | 8-K | $1.85 $1.82 | ▲ +1.62% | ▲ +1.01% | $1.03 (+44.32%) |
May 12, 2026 23w ago | Press Release | $1.85 $1.82 | ▼ −1.62% | ▼ −1.01% | $1.03 (−44.32%) |
Apr 21, 2026 27w ago | Press Release | $1.92 $1.78 | ▼ −7.29% | ▼ −12.21% | $1.03 (−46.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers